These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6396563)
21. CHOP treatment of childhood acute myelogenous leukemia with monocytic differentiation: a report on five cases. Urasiński T; Podraza W Haematol Blood Transfus; 1987; 30():403-5. PubMed ID: 3476373 [TBL] [Abstract][Full Text] [Related]
22. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. Mori M; Kitamura K; Masuda M; Hotta T; Miyazaki T; Miura AB; Mizoguchi H; Shibata A; Saito H; Matsuda T; Masaoka T; Harada M; Niho Y; Takaku F Int J Hematol; 2005 Apr; 81(3):246-54. PubMed ID: 15814336 [TBL] [Abstract][Full Text] [Related]
23. Into the wild world of eosinophilic granuloma. Dhull AK; Aggarwal S; Kaushal V; Singh S BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24252836 [TBL] [Abstract][Full Text] [Related]
24. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission]. Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049 [TBL] [Abstract][Full Text] [Related]
25. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256 [TBL] [Abstract][Full Text] [Related]
26. [Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature]. Mounedji-Boudiaf L; Culine S; Devoldère G; Terrier-Lacombe MJ; Kattan J; Cazier A; Farhat F; Bekradda M; Droz JP Bull Cancer; 1994 Apr; 81(4):334-7. PubMed ID: 7703552 [TBL] [Abstract][Full Text] [Related]
27. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone. Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969 [TBL] [Abstract][Full Text] [Related]
28. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. Alliot C J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060 [No Abstract] [Full Text] [Related]
29. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma. Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536 [TBL] [Abstract][Full Text] [Related]
30. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response. Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333 [TBL] [Abstract][Full Text] [Related]
31. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764 [TBL] [Abstract][Full Text] [Related]
32. [Case of malignant histiocytosis treated with chop therapy and splenectomy]. Kitano Y; Nakagawa M; Kojima M; Kumagai H; Tani G; Komatsu M; Nara M; Nakano S; Oyashiki K; Toyama K Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):990-2. PubMed ID: 7964055 [No Abstract] [Full Text] [Related]
33. Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. Vose JM; Link BK; Grossbard ML; Czuczman M; Grillo-Lopez A; Gilman P; Lowe A; Kunkel LA; Fisher RI J Clin Oncol; 2001 Jan; 19(2):389-97. PubMed ID: 11208830 [TBL] [Abstract][Full Text] [Related]
34. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial. Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436 [TBL] [Abstract][Full Text] [Related]
35. [Vertebral eosinophilic granuloma and spinal cord compression]. Mayer M; Gangemi MG; Sainte-Rose C Arch Fr Pediatr; 1985; 42(6):441-2. PubMed ID: 4051674 [TBL] [Abstract][Full Text] [Related]
36. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089 [TBL] [Abstract][Full Text] [Related]
37. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. Verdonck LF; van Putten WL; Hagenbeek A; Schouten HC; Sonneveld P; van Imhoff GW; Kluin-Nelemans HC; Raemaekers JM; van Oers RH; Haak HL N Engl J Med; 1995 Apr; 332(16):1045-51. PubMed ID: 7898521 [TBL] [Abstract][Full Text] [Related]
38. [Spinal cord compression as the presenting form of non-Hodgkin's lymphoma]. Amigo ML; Revilla R; Sánchez C; del Cañizo C; Caballero D; San Miguel JF Sangre (Barc); 1995 Dec; 40(6):505-7. PubMed ID: 8850235 [TBL] [Abstract][Full Text] [Related]
39. [A case report of neoplastic angioendotheliosis which responded to a combination chemotherapy (CHOP)]. Shiozaki H; Hoshino S; Oshimi K; Mizoguchi H; Tsuzuki C; Hidano A; Mori S Nihon Naika Gakkai Zasshi; 1984 Mar; 73(3):374-8. PubMed ID: 6547466 [No Abstract] [Full Text] [Related]
40. Prognostic factors in elderly patients with non-Hodgkin's lymphoma treated with cyclophosphamide, vincristine, prednisone, bleomycin, Adriamycin, procarbazine (COP-BLAM) therapy. Niitsu N Acta Haematol; 1997; 98(3):130-5. PubMed ID: 9352742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]